Peter Reizenstein
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 65
- Acute Myeloid Leukemia Research 38
- Iron Metabolism and Disorders 12
- Hematopoietic Stem Cell Transplantation 11
- Oncology 38
- Cancer Treatment and Pharmacology 11
- Co-authors
- Leif Stenke (14 shared papers)G Mathé (12 shared papers)Robert Hast (21 shared papers)E. P. Cronkite (5 shared papers)Astrid Gruber (3 shared papers)Mahmoud Mansour (4 shared papers)S Höglund (7 shared papers)S.H. Cohn (2 shared papers)
- Journals
- Acta Haematologica (11 papers)Leukemia Research (10 papers)Digestive Diseases and Sciences (8 papers)Blood (7 papers)Cancer Immunology Immunotherapy (5 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Peter Reizenstein
213 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 122
- Hematology 607
- Genetics 235
- Rheumatology 283
- Oncology 397
- Nutrition and Dietetics 231
Countries citing papers authored by Peter Reizenstein
This map shows the geographic impact of Peter Reizenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Reizenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Reizenstein more than expected).
Fields of papers citing papers by Peter Reizenstein
This network shows the impact of papers produced by Peter Reizenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Reizenstein. The network helps show where Peter Reizenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Reizenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 227 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 78 | |
| 2 | 1985 | 69 | |
| 3 | 1988 | 66 | |
| 4 | 1958 | 57 | |
| 5 | 1992 | 52 | |
| 6 | 1993 | 52 | |
| 7 | 1991 | 48 | |
| 8 | 1961 | 46 | |
| 9 | 1980 | 40 | |
| 10 | 1979 | 38 | |
| 11 | 1962 | 37 | |
| 12 | Formation and effects of leukotrienes and lipoxins in human bone marrow. | 1993 | 36 |
| 13 | Leukotriene production by fresh human bone marrow cells: evidence of altered lipoxygenase activity in chronic myelocytic leukemia. | 1987 | 33 |
| 14 | 1978 | 30 | |
| 15 | 1960 | 30 | |
| 16 | 1987 | 29 | |
| 17 | 1990 | 27 | |
| 18 | 1963 | 27 | |
| 19 | 1966 | 27 | |
| 20 | 2000 | 26 |
About Peter Reizenstein
Peter Reizenstein is a scholar working on Hematology, Oncology, Immunology, Genetics and Molecular Biology, having authored 227 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (38 papers), Acute Lymphoblastic Leukemia research (17 papers), Immune Cell Function and Interaction (17 papers), Folate and B Vitamins Research (16 papers), Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (12 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Hematology (607 citations), Genetics (235 citations), Rheumatology (283 citations), Oncology (397 citations) and Nutrition and Dietetics (231 citations). Peter Reizenstein has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Leif Stenke, G Mathé, Robert Hast, E. P. Cronkite, Astrid Gruber, Mahmoud Mansour, S Höglund, S.H. Cohn, Curt Peterson and Åke Öst. Their work appears in journals such as Acta Haematologica, Leukemia Research, Digestive Diseases and Sciences, Blood and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.